期刊文献+

Liver transplantation for nonalcoholic fatty liver disease:New challenges and new opportunities 被引量:17

Liver transplantation for nonalcoholic fatty liver disease:New challenges and new opportunities
下载PDF
导出
摘要 Nonalcoholic fatty liver disease(NAFLD)is becoming rapidly one of the most common indications for orthotopic liver transplantation in the world.Development of graft steatosis is a significant problem during the posttransplant course,which may happen as a recurrence of pre-existing disease or de novo NAFLD.There are different risk factors that might play a role in development of graft steatosis including post-transplant metabolic syndrome,immune-suppressive medications,genetics and others.There are few studies that assessed the effects of NAFLD on graft and patient survival;most of them were limited by the duration of follow up or by the number of patients.With this review article we will try to shed light on post-liver transplantation NAFLD,significance of the disease,how it develops,risk factors,clinical course and treatment options. Nonalcoholic fatty liver disease (NAFLD) is becoming rapidly one of the most common indications for orthotopic liver transplantation in the world. Development of graft steatosis is a significant problem during the post-transplant course, which may happen as a recurrence of pre-existing disease or de novo NAFLD. There are different risk factors that might play a role in development of graft steatosis including post-transplant metabolic syndrome, immune-suppressive medications, genetics and others. There are few studies that assessed the effects of NAFLD on graft and patient survival; most of them were limited by the duration of follow up or by the number of patients. With this review article we will try to shed light on post-liver transplantation NAFLD, significance of the disease, how it develops, risk factors, clinical course and treatment options.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第18期5320-5330,共11页 世界胃肠病学杂志(英文版)
关键词 Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Liver cirrhosis Liver transplantation Metabolic syndrome Nonalcoholic fatty liver disease Nonalcoholic stea
  • 相关文献

参考文献12

  • 1Paschalis Paschos,Konstantinos Tziomalos.Nonalcoholic fatty liver disease and the renin-angiotensin system:Implications for treatment[J].World Journal of Hepatology,2012,4(12):327-331. 被引量:12
  • 2Eric R Kallwitz.Metabolic syndrome after liver transplantation: Preventable illness or common consequence?[J].World Journal of Gastroenterology,2012,18(28):3627-3634. 被引量:3
  • 3Marno C. Ryan,Catherine Itsiopoulos,Tania Thodis,Glenn Ward,Nicholas Trost,Sophie Hofferberth,Kerin O’Dea,Paul V. Desmond,Nathan A. Johnson,Andrew M. Wilson.The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease[J].Journal of Hepatology.2013(1) 被引量:6
  • 4Armin Finkenstedt,Claudia Auer,Bernhard Glodny,Ursula Posch,Hansjoerg Steitzer,Gerhard Lanzer,Johann Pratschke,Matthias Biebl,Michael Steurer,Ivo Graziadei,Wolfgang Vogel,Heinz Zoller.PNPLA3 rs738409-G in Recipients of Liver Transplants is a Risk Factor for Graft Steatosis[J].Clinical Gastroenterology and Hepatology.2013 被引量:2
  • 5Sunder Mudaliar,Robert R. Henry,Arun J. Sanyal,Linda Morrow,Hanns-Ulrich Marschall,Mark Kipnes,Luciano Adorini,Cathi I. Sciacca,Paul Clopton,Erin Castelloe,Paul Dillon,Mark Pruzanski,David Shapiro.Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease[J].Gastroenterology.2013 被引量:7
  • 6J. K. Heimbach,K. D. S. Watt,J. J. Poterucha,N. Francisco Ziller,S. D. Cecco,M. R. Charlton,J. E. Hay,R. H. Wiesner,W. Sanchez,C. B. Rosen,J. M. Swain.Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End‐Stage Liver Disease[J].American Journal of Transplantation.2012(2) 被引量:3
  • 7Qing-Jun Wu,Feng-Chun Zhang,Xuan Zhang.Adamantiades-Behcet's disease-complicated gastroenteropathy[J].World Journal of Gastroenterology,2012,18(7):609-615. 被引量:33
  • 8Salvatore Petta,Stefania Grimaudo,Calogero Cammà,Daniela Cabibi,Vito Di Marco,Giusalba Licata,Rosaria Maria Pipitone,Antonio Craxì.IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease[J].Journal of Hepatology.2012(6) 被引量:2
  • 9Hideharu Shimizu,Viet Phuong,Munique Maia,Matthew Kroh,Bipan Chand,Philip R. Schauer,Stacy A. Brethauer.Bariatric surgery in patients with liver cirrhosis[J].Surgery for Obesity and Related Diseases.2012 被引量:1
  • 10Paul Clark,Alexander Thompson,Qianqian Zhu,David Vock,Mingfu Zhu,Keyur Patel,Stephen Harrison,Susanna Naggie,Dongliang Ge,Hans Tillmann,Thomas Urban,Kevin Shianna,Jacques Fellay,Zachary Goodman,Stephanie Noviello,Lisa Pedicone,Nezam Afdhal,Mark Sulkowski,Janice Albrecht,David Goldstein,John McHutchison,Andrew Muir.The Association of Genetic Variants with Hepatic Steatosis in Patients with Genotype 1 Chronic Hepatitis C Infection[J].Digestive Diseases and Sciences.2012(8) 被引量:1

二级参考文献123

  • 1Silvia Sookoian,María Alejandra Fernández,Gustavo Casta(n|~)o.Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study[J].World Journal of Gastroenterology,2005,11(48):7560-7563. 被引量:7
  • 2Soichiro Fujiwara,Ichiro Shimizu,Momoko Ishikawa,Kohzo Uehara,Hirofumi Yamamoto,Michiyo Okazaki,Takahiro Horie,Arata luchi,Susumu Ito.Intestinal Behcet's disease with esophageal ulcers and colonic longitudinal ulcers[J].World Journal of Gastroenterology,2006,12(16):2622-2624. 被引量:8
  • 3Painter PL, Luetkemeier MJ, Moore GE, Dibble SL, Green GA, Myll JO, Carlson LL. Health-related fitness and quality of life in organ transplant recipients. Transplantation 1997; 64: 1795-1800. 被引量:1
  • 4Pirenne J, Van Gelder F, Kharkevitch T, Nevens F, Verslype C, Peetermans WE, Kitade H, Vanhees L, Devos Y, Hauser M, Hamoir E, Noizat-Pirenne F, Pirotte B. Tolerance of liver transplant patients to strenuous physical activity in high- altitude. Am J Transplant 2004; 4:554-560. 被引量:1
  • 5Stephenson'AL, Yoshida E1VI, Abboud RT, Fradet G, Levy RD. Impaired exercise performance after successful liver transplantation. Transplantation 2001; 72:1161-1164. 被引量:1
  • 6Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplan- tation 1995; 60:1057-1060. 被引量:1
  • 7Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetter- man RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg 1998; 4:285-296. 被引量:1
  • 8Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int 2005; 18: 461-466. 被引量:1
  • 9Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14: 1648-1654. 被引量:1
  • 10Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, Lopez R, Zein NN. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transp12008; 14:1287-1293. 被引量:1

共引文献61

同被引文献97

引证文献17

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部